Skip to content

eqosSphere NG

Active Private limited companyfounded 2016active for 10 yearsAllée Nord (Baconval) 1, 5651 WalcourtKBO/BCE: BE 0648.802.613

Board

2 directors, last change in 2024
Director (not named in the articles)
appointed by deed of 17-05-2024 term without a fixed end
Colette Vincent
Director
listed in the 2022 annual accounts, filed on 15-06-2023
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Article 12. Pouvoirs de l’organe d’administration S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est…”
deed of 19-12-2023

Office holders in the KBO →

Mandates through the years

5 names, the dashed line is today
Colette Vincent
Director
LURQUIN Pascal
Director (not named in the articles)
XHARDEZ Philippe Alain
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
  • Colette Vincent
    • Director, since before 31-12-2021
  • LURQUIN Pascal
    • Director (not named in the articles), appointed by deed of 17-05-2024, still in office
  • XHARDEZ Philippe Alain
    • Director (not named in the articles), from before 31-12-2021 to 17-05-2024
    • Manager, until 19-12-2023
  • COLLETTE Vincent Marie
    • Manager, until 19-12-2023
  • JAUME Michaël Marie
    • Manager, from before 31-12-2021 to 19-12-2023

Control

This company
eqosSphere NG
Equity €33,310
Profit €16,488 in 2025

Capital

Contribution
€6,765
Source
deed of 19-12-2023

Articles of association

deed of 19-12-2023 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié à charge du cédant,moitié à charge du ou des acquéreurs proportionnellement au nombre d'actions acquises, cession d'actions”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Thursday of June at 20:00

Shareholders

Next steps